{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:01:53Z","timestamp":1781614913661,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"publisher","award":["0026\/2019-00"],"award-info":[{"award-number":["0026\/2019-00"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Comorbidities are frequently present in patients with axial spondyloarthritis (axSpA) and may contribute to poorer health-related outcomes. Patient-reported outcomes (PROs) serve as tools to assess the patient\u2019s perspective on the burden of the disease. The study aimed to evaluating the impact of comorbidities on selected PROs in axSpA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>Adult patients diagnosed with axSpA based on ASAS classification criteria were included in this cross-sectional study. Data collected included comorbidities and PROs [Health Assessment Questionnaire (HAQ), Multi-Dimensional Health Assessment Questionnaire (MDHAQ), 36-Item Short Form Health Survey (SF-36), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Bath Ankylosing Spondylitis Functional Index (BASFI)].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, 323 participants were included in the study (44.0% female). Multimorbidity and extended multimorbidity were observed in 63.8% and 38.7% of patients, respectively. Extended multimorbidity was associated with higher HAQ (0.5 [0.1\u20131.0] vs. 0.3 [0.0\u20130.8], <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) and MDHAQ scores (0.3 [0.0\u20130.6] vs. 0.1 [0.0\u20130.5], <jats:italic>p<\/jats:italic>\u2009=\u20090.03). The BASDAI score was higher in patients with three or more comorbidities than in patients with no comorbidities (2.8 [1.7\u20134.3] vs. 1.9 [0.9\u20133.6], <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). The number of comorbidities was associated with higher scores in the mental health (<jats:italic>\u03b2<\/jats:italic>\u2009=\u20090.20, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) and vitality (<jats:italic>\u03b2<\/jats:italic>\u2009=\u20090.16, <jats:italic>p<\/jats:italic>\u2009=\u20090.02) domains of the SF-36 questionnaire.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Multimorbidity was present in almost two-thirds of cases. Extended multimorbidity was associated with poorer physical functioning, HAQ, MDHAQ, and BASDAI scores, whereas multimorbidity was related to better scores in the mental health and vitality domains. The impact of comorbidities on PROs in axSpA should not be overlooked.\n<jats:table-wrap>\n                <jats:table>\n                  <jats:tbody>\n                    <jats:tr>\n                      <jats:td colspan=\"2\">\n                        <jats:bold>Key Points<\/jats:bold>\u2022 <jats:italic>Multimorbidity is frequent among axial spondyloarthritis\u2019 patients<\/jats:italic>.\u2022 <jats:italic>Only extended multimorbidity (presence of two or more additional diseases, excluding axial spondyloarthritis) was found to be associated with poorer results of patient-reported outcomes, in particular these regarding physical functioning<\/jats:italic>.\u2022 <jats:italic>Multimorbidity might influence positively some domains of quality of life such as mental health or vitality<\/jats:italic>.\u2022 <jats:italic>The findings included in the study support the belief that in patients with spondyloarthritis comorbidities might impact patient-reported outcomes which are important when assessing disease activity and response to treatment and should not be disregarded<\/jats:italic>.<\/jats:td>\n                    <\/jats:tr>\n                  <\/jats:tbody>\n                <\/jats:table>\n              <\/jats:table-wrap>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10067-025-07452-6","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T23:42:14Z","timestamp":1746574934000},"page":"2311-2320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associations between comorbidities and patient-reported outcomes in axial spondyloarthritis: data from a single-center real-world cohort"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2643-9818","authenticated-orcid":false,"given":"Grzegorz","family":"Biedro\u0144","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7967-0880","authenticated-orcid":false,"given":"Mateusz","family":"Wilk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-7581","authenticated-orcid":false,"given":"Jaros\u0142aw","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2031-6657","authenticated-orcid":false,"given":"Piotr","family":"Kuszmiersz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-6469","authenticated-orcid":false,"given":"Zofia","family":"Gu\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5449-0680","authenticated-orcid":false,"given":"Magdalena","family":"Strach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-8947","authenticated-orcid":false,"given":"Alen","family":"Brkic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9279-5191","authenticated-orcid":false,"given":"Glenn","family":"Haugeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9739","authenticated-orcid":false,"given":"Mariusz","family":"Korkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"7452_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2217\/ijr.12.61","volume":"7","author":"S Lipton","year":"2012","unstructured":"Lipton S, Deodhar A (2012) The new ASAS classification criteria for axial and peripheral spondyloarthritis: promises and pitfalls. Int J Clin Rheumatol 7:675\u2013682. https:\/\/doi.org\/10.2217\/ijr.12.61","journal-title":"Int J Clin Rheumatol"},{"issue":"2","key":"7452_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41584-020-00552-4","volume":"17","author":"PC Robinson","year":"2021","unstructured":"Robinson PC, Van Der Linden S, Khan MA, Taylor WJ (2021) Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nat Rev Rheumatol 17(2):109\u2013118. https:\/\/doi.org\/10.1038\/s41584-020-00552-4","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"7452_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Van Der Linden","year":"1984","unstructured":"Van Der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York Criteria. Arthritis Rheum 27(4):361\u20138. https:\/\/doi.org\/10.1002\/art.1780270401","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7452_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Van Der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, S\u00f8rensen IJ, Ozgocmen S, Roussou E, Valle-O\u00f1ate R, Weber U, Wei J, Sieper J (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777\u201383. https:\/\/doi.org\/10.1136\/ard.2009.108233. (Erratum in: Ann Rheum Dis. 2019 Jun;78(6):e59. 10.1136\/ard.2009.108233corr1)","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"7452_CR5","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/acr.22831","volume":"68","author":"C Stolwijk","year":"2016","unstructured":"Stolwijk C (2016) Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis. Arthritis Care Res (Hoboken) 68(9):1320\u201331. https:\/\/doi.org\/10.1002\/acr.22831","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"7452_CR6","first-page":"263","volume":"36","author":"R Bohn","year":"2018","unstructured":"Bohn R, Cooney M, Deodhar A, Curtis JR, Golembesky A (2018) Incidence and prevalence of axial spondyloarthritis: methodologic challenges and gaps in the literature. Clin Exp Rheumatol 36(2):263\u2013274","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 3","key":"7452_CR7","doi-asserted-by":"publisher","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","volume":"61 Suppl 3","author":"J Sieper","year":"2002","unstructured":"Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61 Suppl 3(Suppl 3):iii8-18. https:\/\/doi.org\/10.1136\/ard.61.suppl_3.iii8","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7452_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landew\u00e9 RBM, Van den Bosch FE, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen FA, G\u00e9her P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, L\u00f3pez-Medina C, Machado PM, Marzo-Ortega H, Molto A, Navarro-Comp\u00e1n V, Nissen MJ, Pimentel-Santos FM, Poddubnyy D, Proft F, Rudwaleit M, Telkman M, Zhao SS, Ziade N, van der Heijde D (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7452_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/BOR.0b013e3283521c64","volume":"24","author":"M Her","year":"2012","unstructured":"Her M, Kavanaugh A (2012) Patient-reported outcomes in rheumatoid arthritis. Curr Opin Rheumatol 24(3):327\u201334. https:\/\/doi.org\/10.1097\/BOR.0b013e3283521c64","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"7452_CR10","doi-asserted-by":"publisher","first-page":"e000019","DOI":"10.1136\/rmdopen-2014-000019","volume":"1","author":"L Gossec","year":"2015","unstructured":"Gossec L, Dougados M, Dixon W (2015) Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis. RMD Open 1(1):e000019. https:\/\/doi.org\/10.1136\/rmdopen-2014-000019","journal-title":"RMD Open"},{"issue":"1","key":"7452_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40744-021-00289-w","volume":"8","author":"SD Chakravarty","year":"2021","unstructured":"Chakravarty SD, Abell J, Leone-Perkins M, Orbai AM (2021) A novel qualitative study assessing patient-reported outcome measures among people living with psoriatic arthritis or ankylosing spondylitis. Rheumatol Ther 8(1):609\u2013620. https:\/\/doi.org\/10.1007\/s40744-021-00289-w","journal-title":"Rheumatol Ther"},{"key":"7452_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-1-20","volume":"1","author":"B Bruce","year":"2003","unstructured":"Bruce B, Fries JF (2003) The stanford health assessment questionnaire: dimensions and practical applications. Health Qual Life Outcomes 1:20. https:\/\/doi.org\/10.1186\/1477-7525-1-20","journal-title":"Health Qual Life Outcomes"},{"issue":"10","key":"7452_CR13","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1002\/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5","volume":"42","author":"T Pincus","year":"1999","unstructured":"Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42(10):2220\u201330. https:\/\/doi.org\/10.1002\/1529-0131(199910)42:10%3c2220::AID-ANR26%3e3.0.CO;2-5","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7452_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473\u201383","journal-title":"Med Care"},{"issue":"12","key":"7452_CR15","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286\u201391","journal-title":"J Rheumatol"},{"issue":"12","key":"7452_CR16","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281\u20135","journal-title":"J Rheumatol"},{"issue":"6","key":"7452_CR17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00296-024-05583-8","volume":"44","author":"M Wilk","year":"2024","unstructured":"Wilk M, Zimba O, Haugeberg G, Korkosz M (2024) Pain catastrophizing in rheumatic diseases: prevalence, origin, and implications. Rheumatol Int 44(6):985\u20131002. https:\/\/doi.org\/10.1007\/s00296-024-05583-8","journal-title":"Rheumatol Int"},{"issue":"6","key":"7452_CR18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","volume":"75","author":"A Molt\u00f3","year":"2016","unstructured":"Molt\u00f3 A, Etcheto A, van der Heijde D, Landew\u00e9 R, van den Bosch F, Bautista Molano W, Burgos-Vargas R, Cheung PP, Collantes-Estevez E, Deodhar A, El-Zorkany B, Erdes S, Gu J, Hajjaj-Hassouni N, Kiltz U, Kim TH, Kishimoto M, Luo SF, Machado PM, Maksymowych WP, Maldonado-Cocco J, Marzo-Ortega H, Montecucco CM, Ozgo\u00e7men S, van Gaalen F, Dougados M (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75(6):1016\u201323. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208174","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7452_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3899\/jrheum.170520","volume":"45","author":"W Bautista-Molano","year":"2018","unstructured":"Bautista-Molano W, Landew\u00e9 R, Burgos-Vargas R, Maldonado-Cocco J, Molt\u00f3 A, van den Bosch F, Valle-O\u00f1ate R, Dougados M, van der Heijde D (2018) Prevalence of comorbidities and risk factors for comorbidities in patients with spondyloarthritis in Latin America: a comparative study with the general population and data from the ASAS-COMOSPA Study. J Rheumatol 45(2):206\u2013212. https:\/\/doi.org\/10.3899\/jrheum.170520","journal-title":"J Rheumatol"},{"issue":"2","key":"7452_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10067-017-3905-1","volume":"37","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Zhang P, Tu L, Lv Q, Qi J, Lin Z, Liao Z, Cao S, Gu J (2018) Prevalence of comorbidities and evaluation of screening in Chinese patients with spondyloarthritis. Clin Rheumatol 37(2):423\u2013428. https:\/\/doi.org\/10.1007\/s10067-017-3905-1","journal-title":"Clin Rheumatol"},{"issue":"2","key":"7452_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jphs.12212","volume":"9","author":"JA Walsh","year":"2018","unstructured":"Walsh JA, Song X, Kim G, Park Y (2018) Evaluation of the comorbidity burden in patients with ankylosing spondylitis treated with tumour necrosis factor inhibitors using a large administrative claims data set. J Pharm Heal Serv Res 9(2):115\u2013121. https:\/\/doi.org\/10.1111\/jphs.12212","journal-title":"J Pharm Heal Serv Res"},{"issue":"7","key":"7452_CR22","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1136\/annrheumdis-2017-212629","volume":"77","author":"I Redeker","year":"2018","unstructured":"Redeker I, Hoffmann F, Callhoff J, Haibel H, Sieper J, Zink A, Poddubnyy D (2018) Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. Ann Rheum Dis 77(7):1017\u20131024. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212629","journal-title":"Ann Rheum Dis"},{"issue":"Suppl4","key":"7452_CR23","doi-asserted-by":"publisher","first-page":"iv47","DOI":"10.1093\/rheumatology\/keaa246","volume":"59","author":"SS Zhao","year":"2020","unstructured":"Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ (2020) Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology (Oxford) 59(Suppl4):iv47\u2013iv57. https:\/\/doi.org\/10.1093\/rheumatology\/keaa246","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"7452_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13075-020-02301-0","volume":"22","author":"I Redeker","year":"2020","unstructured":"Redeker I, Callhoff J, Hoffmann F, Marschall U, Haibel H, Sieper J, Zink A, Poddubnyy D (2020) The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study. Arthritis Res Ther 22(1):210. https:\/\/doi.org\/10.1186\/s13075-020-02301-0","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"7452_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.46497\/ArchRheumatol.2023.9793","volume":"38","author":"HF \u00c7ay","year":"2022","unstructured":"\u00c7ay HF, AlkanMeliko\u011flu M, Yurdakul FG, Bodur H, Ataman \u015e, \u00c7apk\u0131n E, G\u00fcrer G, Sezer \u0130, Duru\u00f6z MT, Rezvani A, Ya\u011fc\u0131 \u0130, G\u00f6\u011f\u00fc\u015f F, Kamanli A, \u00c7evik R, Akg\u00fcl \u00d6 (2022) Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar. Arch Rheumatol 38(3):333\u2013346. https:\/\/doi.org\/10.46497\/ArchRheumatol.2023.9793","journal-title":"Arch Rheumatol"},{"issue":"3","key":"7452_CR26","doi-asserted-by":"publisher","first-page":"101857","DOI":"10.1016\/j.berh.2023.101857","volume":"37","author":"P Bosch","year":"2023","unstructured":"Bosch P, Zhao SS, Nikiphorou E (2023) The association between comorbidities and disease activity in spondyloarthritis \u2013 a narrative review. Best Pract Res Clin Rheumatol 37(3):101857. https:\/\/doi.org\/10.1016\/j.berh.2023.101857","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"7452_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrrheum.2013.212","volume":"10","author":"H Radner","year":"2014","unstructured":"Radner H, Yoshida K, Smolen JS, Solomon DH (2014) Multimorbidity and rheumatic conditions - enhancing the concept of comorbidity. Nat Rev Rheumatol 10(4):252\u20136. https:\/\/doi.org\/10.1038\/nrrheum.2013.212","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"7452_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13075-015-0716-0","volume":"17","author":"G Haugeberg","year":"2015","unstructured":"Haugeberg G, Hansen IJW, Soldal DM, Sokka T (2015) Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. Arthritis Res Ther 17(1):219. https:\/\/doi.org\/10.1186\/s13075-015-0716-0","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"7452_CR29","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/acr.23468","volume":"70","author":"E Nikiphorou","year":"2018","unstructured":"Nikiphorou E, Ramiro S, van der Heijde D, Norton S, Molt\u00f3 A, Dougados M, van den Bosch F, Landew\u00e9 R (2018) Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study Task Force. Association of Comorbidities in Spondyloarthritis With Poor Function, Work Disability, and Quality of Life: Results From the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study. Arthritis Care Res (Hoboken) 70(8):1257\u20131262. https:\/\/doi.org\/10.1002\/acr.23468","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"7452_CR30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3899\/jrheum.181415","volume":"47","author":"G Fitzgerald","year":"2020","unstructured":"Fitzgerald G, Gallagher P, O\u2019Shea FD (2020) Multimorbidity in axial spondyloarthropathy and its association with disease outcomes: results from the ankylosing spondylitis registry of Ireland cohort. J Rheumatol 47(2):218\u2013226. https:\/\/doi.org\/10.3899\/jrheum.181415","journal-title":"J Rheumatol"},{"issue":"7","key":"7452_CR31","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1093\/rheumatology\/keaa768","volume":"60","author":"SS Zhao","year":"2021","unstructured":"Zhao SS, Jones GT, Macfarlane GJ, Hughes DM, Moots RJ, Goodson NJ (2021) Association between comorbidities and disease activity in axial spondyloarthritis: results from the BSRBR-AS. Rheumatology (Oxford) 60(7):3189\u20133198. https:\/\/doi.org\/10.1093\/rheumatology\/keaa768","journal-title":"Rheumatology (Oxford)"},{"issue":"9836","key":"7452_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380(9836):37\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(12)60240-2","journal-title":"Lancet"},{"issue":"4","key":"7452_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.semarthrit.2008.01.004","volume":"38","author":"E Loza","year":"2009","unstructured":"Loza E, Jover JA, Rodriguez L, Carmona L (2009) Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease. Semin Arthritis Rheum 38(4):312\u20139. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.01.004","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"7452_CR34","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/rheumatology\/ket354","volume":"53","author":"C Stolwijk","year":"2014","unstructured":"Stolwijk C, van Tubergen A, Ramiro S, Essers I, Blaauw M, van der Heijde D, Landew\u00e9 R, van den Bosch F, Dougados M, Boonen A (2014) Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis. Rheumatology (Oxford) 53(6):1054\u201364. https:\/\/doi.org\/10.1093\/rheumatology\/ket354","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"7452_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5472\/MMJoa.2901.0","volume":"29","author":"Y Garip","year":"2016","unstructured":"Garip Y, Eser F, Guler T, Dortbas F, Kilicarlsan A, Bodur H (2016) Comorbidity profiles among patients with ankylosing spondylitis. Marmara Med J 29(1):23. https:\/\/doi.org\/10.5472\/MMJoa.2901.0","journal-title":"Marmara Med J"},{"issue":"2","key":"7452_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/rheumatology\/keq334","volume":"50","author":"H Radner","year":"2011","unstructured":"Radner H, Smolen JS, Aletaha D (2011) Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology 50(2):381\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keq334","journal-title":"Rheumatology"},{"issue":"8","key":"7452_CR37","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00296-024-05632-2","volume":"44","author":"G Biedro\u0144","year":"2024","unstructured":"Biedro\u0144 G, Wilk M, Nowakowski J, Kuszmiersz P, Gu\u0142a Z, Strach M, Brkic A, Haugeberg G, Korkosz M (2024) Impact of comorbidities on patient-reported outcomes in psoriatic arthritis: a single centre cohort study. Rheumatol Int 44(8):1435\u20131443. https:\/\/doi.org\/10.1007\/s00296-024-05632-2","journal-title":"Rheumatol Int"},{"issue":"9","key":"7452_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00296-007-0344-3","volume":"27","author":"V Aloush","year":"2007","unstructured":"Aloush V, Ablin JN, Reitblat T, Caspi D, Elkayam O (2007) Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int 27(9):865\u2013868. https:\/\/doi.org\/10.1007\/s00296-007-0344-3","journal-title":"Rheumatol Int"},{"issue":"6 Suppl 63","key":"7452_CR39","first-page":"S33","volume":"28","author":"R Almod\u00f3var","year":"2010","unstructured":"Almod\u00f3var R, Carmona L, Zarco P, Collantes E, Gonz\u00e1lez C, Mulero J, Sueiro JL, Gratac\u00f3s J, Torre-Alonso JC, Juanola X, Batlle E, Ariza R, Font P (2010) Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol 28(6 Suppl 63):S33\u2013S39","journal-title":"Clin Exp Rheumatol"},{"key":"7452_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13075-016-0943-z","volume":"18","author":"N Bello","year":"2016","unstructured":"Bello N, Etcheto A, B\u00e9al C, Dougados M, Molt\u00f3 A (2016) Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Res Ther 18:42. https:\/\/doi.org\/10.1186\/s13075-016-0943-z","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"7452_CR41","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/art.40185","volume":"69","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane GJ, Barnish MS, Pathan E, Martin KR, Haywood KL, Siebert S, Packham J, Atzeni F, Jones GT (2017) Co-occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: results from a UK National Register. Arthritis Rheumatol 69(11):2144\u20132150. https:\/\/doi.org\/10.1002\/art.40185","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"7452_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10067-010-1581-5","volume":"30","author":"E Roussou","year":"2011","unstructured":"Roussou E, Sultana S (2011) Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides. Clin Rheumatol 30(1):121\u20137. https:\/\/doi.org\/10.1007\/s10067-010-1581-5","journal-title":"Clin Rheumatol"},{"issue":"4","key":"7452_CR43","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/rheumatology\/keae370","volume":"64","author":"P Hellamand","year":"2025","unstructured":"Hellamand P, van de Sande MGH, Nurmohamed MT, van Vollenhoven RF, Hollick RJ, Rotariu O, Rotar Z, Pirkmajer KP, Nordstr\u00f6m D, Hokkanen AM, Michelsen B, Kvien TK, Glintborg B, Hetland ML, \u00d8stergaard M, Loft AG, Pavelka K, Zavada J, Castrejon I, Otero-Varela L, Gudbjornsson B, Palsson O, Olofsson T, Wallman JK, Ciurea A, Nissen MJ, Yildirim TD, Onen F, Codreanu C, Mogosan C, Santos MJ, Vieira-Sousa E, Iannone F, Frediani B, \u00d8rnbjerg LM, Twisk JWR, van der Horst-Bruinsma IE (2025) Sex differences in patient-reported outcome measures\u00a0and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors. Rheumatology (Oxford) 64(4):1853\u20131863. https:\/\/doi.org\/10.1093\/rheumatology\/keae370","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"7452_CR44","doi-asserted-by":"publisher","first-page":"e003776","DOI":"10.1136\/rmdopen-2023-003776","volume":"10","author":"M Llop","year":"2024","unstructured":"Llop M, Gratac\u00f3s J, Moreno M, Arevalo Salaet M, Calvet J, Berenguer-Llergo A, Dougados M, Molto A, L\u00f3pez-Medina C (2024) Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study. RMD Open 10(1):e003776. https:\/\/doi.org\/10.1136\/rmdopen-2023-003776","journal-title":"RMD Open"},{"issue":"1","key":"7452_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13075-023-03184-7","volume":"25","author":"L Linde","year":"2023","unstructured":"Linde L, \u00d8rnbjerg LM, Rasmussen SH, Love TJ, Loft AG, Z\u00e1vada J, Vencovsk\u00fd J, Laas K, Nordstrom D, Sokka-Isler T, Gudbjornsson B, Gr\u00f6ndal G, Iannone F, Ramonda R, Hellamand P, Kristianslund EK, Kvien TK, Rodrigues AM, Santos MJ, Codreanu C, Rotar Z, Tom\u0161i\u010d M, Castrejon I, D\u00edaz-Gonz\u00e1les F, Di Giuseppe D, Ljung L, Nissen MJ, Ciurea A, Macfarlane GJ, Heddle M, Glintborg B, \u00d8stergaard M, Hetland ML (2023) Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration. Arthritis Res Ther 25(1):205. https:\/\/doi.org\/10.1186\/s13075-023-03184-7","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07452-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:20:44Z","timestamp":1749129644000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07452-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7452"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07452-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The survey\u2019s research protocol was approved by the Institutional Review Board of the Jagiellonian University Medical College (protocol no. 1072.6120.247.2020, 24 September 2020). The study was carried out under the ethical principles of The Declaration of Helsinki (1964).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided informed consent before completing the questionnaire, with the assurance that their responses would be used solely for research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}